Plain-English translation of NCT06718153 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are studying tissue samples that were already removed during your liver cancer surgery to understand how certain visible markers in the tissue match up with genetic mutations found in your cancer. By comparing these markers with genetic test results, the team hopes to develop a better way to classify and diagnose liver cancer that could help doctors make more accurate treatment decisions in the future.
Doctors currently use genetic testing to understand liver cancers, but there's a gap between what the genetic tests show and what doctors can see under the microscope. This study aims to bridge that gap by finding reliable markers that are easier and faster to identify, which could eventually help doctors diagnose and treat liver cancer more effectively.
You likely qualify if…
You likely don't qualify if…
This is a retrospective study, meaning researchers will review your existing medical records and tissue samples that were already collected during your liver surgery — you won't need to undergo any new procedures or visits. Researchers will perform special staining tests on your preserved tissue sample to look for specific markers and compare these findings with your genetic test results that are already on file. The study involves looking back at your past medical information and tissue, with no active participation or follow-up required from you.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
Italy